Detalhe da pesquisa
1.
Systemic sclerosis sine scleroderma in children is more aggressive than in adults.
Rheumatology (Oxford)
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775723
2.
Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study.
Rheumatology (Oxford)
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38745439
3.
Autoantibodies Targeting G-Protein-Coupled Receptors: Pathogenetic, Clinical and Therapeutic Implications in Systemic Sclerosis.
Int J Mol Sci
; 25(4)2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396976
4.
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Int J Mol Sci
; 24(4)2023 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835590
5.
Should we use nintedanib as early therapy in patients with SSc-ILD?
Autoimmun Rev
; 23(1): 103463, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844857
6.
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study.
RMD Open
; 9(1)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813476
7.
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort.
RMD Open
; 9(3)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541742
8.
Children and Adults with PFAPA Syndrome: Similarities and Divergences in a Real-Life Clinical Setting.
Adv Ther
; 38(2): 1078-1093, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33315168